Call: 312-972-6236

    Juvederm Voluma

    INDICATIONS:

    JUVÉDERM VOLUMA ® XC injectable gel is indicated for deep (subcutaneous and/or supraperiosteal) injection for cheek augmentation to correct age-related volume deficit in the mid-face in adults over the age of 21.

    JUVÉDERM® Ultra XC and JUVÉDERM® Ultra Plus XC injectable gels are indicated for injection into the mid-to-deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds).

    JUVÉDERM VOLLURE™ XC injectable gel is indicated for injection into the mid-to-deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) in adults over the age of 21.

    JUVÉDERM® Ultra XC injectable gel is indicated for injection into the lips and perioral area for lip augmentation in adults over the age of 21.

    JUVÉDERM VOLBELLA® XC injectable gel is indicated for injection into the lips for lip augmentation and for correction of perioral rhytids in adults over the age of 21.

     

    IMPORTANT SAFETY INFORMATION:

    CONTRAINDICATIONS:

    These products should not be used in patients who have severe allergies, marked by a history of anaphylaxis or history or presence of multiple severe allergies, and should not be used in patients with a history of allergies to Gram-positive bacterial proteins or lidocaine contained in these products.

    WARNINGS:

    • Do not inject into blood vessels. Introduction of these products into the vasculature may lead to embolization, occlusion of the vessels, ischemia, or infarction. Take extra care when injecting soft-tissue fillers; for example, inject the product slowly and apply the least amount of pressure necessary. Rare, but serious, adverse events associated with the intravascular injection of soft-tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage leading to stroke, skin necrosis, and damage to underlying facial structures. Immediately stop the injection if a patient exhibits any of the following symptoms: changes in vision, signs of a stroke, blanching of the skin, unusual pain during or shortly after the procedure. Patients should receive prompt medical attention and, possibly, evaluation by an appropriate healthcare professional specialist should an intravascular injection occur.
    • Product use at specific sites in which an active inflammatory process (skin eruptions such as cysts, pimples, rashes, or hives) or infection is present should be deferred until the underlying process has been controlled.

    PRECAUTIONS:

    • In order to minimize the risk of potential complications, these products should only be used by healthcare professionals who have appropriate training, experience, and knowledge of facial anatomy.
    • Healthcare professionals are encouraged to discuss the potential risks of soft-tissue injections with their patients prior to treatment and ensure that patients are aware of signs and symptoms of potential complications.
    • The safety and effectiveness for the treatment of anatomic regions other than the mid-face with JUVÉDERM VOLUMA® XC; facial wrinkles and folds with JUVÉDERM® Ultra XC, JUVÉDERM® UltraPlus XC, and JUVÉDERM VOLLURE™ XC; and the lips and perioral area with JUVÉDERM® Ultra XC and JUVÉDERM VOLBELLA® XC have not been established in controlled clinical studies.
    • As with all transcutaneous procedures, dermal filler implantation carries a risk of infection. Follow standard precautions associated with injectable materials.
    • The safety for use during pregnancy, in breastfeeding females, and in patients with known susceptibility to keloid formation, hypertrophic scarring, and pigmentation disorders has not been studied.
    • The safety for use of JUVÉDERM VOLUMA® XC in patients under 35 or over 65 years, JUVÉDERM® Ultra XC and JUVÉDERM® Ultra Plus XC in patients under 18 years, and JUVÉDERM VOLLURE™ XC and JUVÉDERM VOLBELLA® XC in patients under 22 years has not been established.
    • Use with caution in patients on immunosuppressive therapy.
    • Patients who are using products that can prolong bleeding (such as aspirin, nonsteroidal antiinflammatory drugs, and warfarin) may experience increased bruising or bleeding at treatment sites.
    • If laser treatment, chemical peel, or any other procedure based on active dermal response is considered after treatment, or if the product is administered before the skin has healed completely, there is a possible risk of an inflammatory reaction at the treatment site.
    • Patients who experience skin injury near the site of implantation may be at a higher risk for adverse events.
    • The safety of JUVÉDERM VOLUMA® XC injectable gel for use in patients with very thin skin in the mid-face has not been established.
    • Patients may experience late onset nodules with use of dermal fillers, including JUVÉDERM VOLUMA® XC.
    • Patients may experience late onset adverse events with use of dermal fillers.

    ADVERSE EVENTS:

    JUVÉDERM VOLUMA® XC injectable gel is indicated for deep (subcutaneous and/or supraperiosteal) injection for cheek augmentation to correct age-related volume deficit in the mid-face in adults over the age of 21.

    jovuderm voluma

    JUVÉDERM VOLUMA® XC Before-and-After Photo Files

    jovuderm voluma.jpg before and after julia 1

    Actual patient. Results may vary. Unretouched photos taken before treatment and 1 month after treatment with
    JUVÉDERM VOLUMA® XC. A total of 3.0 mL of JUVÉDERM VOLUMA® XC was injected into the cheek area.

    APPROVED USE:

    JUVÉDERM VOLUMA® XC injectable gel is for deep injection in the cheek area to correct age-related
    volume loss in adults over the age of 21.
    IMPORTANT SAFETY INFORMATION
    Are there any reasons why I should not receive JUVÉDERM VOLUMA® XC?
    Do not use if you have a history of multiple severe allergies or severe allergic reactions (anaphylaxis), or
    if you are allergic to the proteins (gram-positive bacterial proteins) used to make hyaluronic acid (HA) or
    to the lidocaine in this product.
    What precautions should my doctor advise me about?
    • Tell your doctor if you are pregnant or breastfeeding. The safety of these products for use during
    pregnancy or while breastfeeding has not been studied
    • The safety of JUVÉDERM VOLUMA® XC in patients under 35 years or over 65 years has not
    been studied
    • The safety and effectiveness of JUVÉDERM VOLUMA® XC in areas other than the cheek area have
    not been established in clinical studies
    • Tell your doctor if you have a history of excessive scarring (eg, hypertrophic scarring and keloid
    formations) or pigmentation disorders, as use of these products may result in additional scars or
    changes in pigmentation
    • Tell your doctor if you are planning other laser treatments or a chemical peel, as there is a possible
    risk of inflammation at the treatment site if these procedures are performed after treatment
    • Patients who experience skin injury near the site of injection with these products may be at higher
    risk for side effects

    • Tell your doctor if you are on immunosuppressive therapy used to decrease the body’s immune
    response, as use of these products may result in an increased risk of infection
    • Tell your doctor if you are using medications that can prolong bleeding, such as aspirin, ibuprofen,
    or other blood thinners, as this may result in increased bruising or bleeding at the injection site
    • Minimize strenuous exercise, exposure to extensive sun or heat, and alcoholic beverages within
    the first 24 hours following treatment
    What are possible side effects?
    The most common side effects include temporary reactions at the treatment site such as tenderness,
    swelling, firmness, lumps/bumps, bruising, pain, redness, discoloration, and itching. Side effects are
    moderate (uncomfortable) and generally last 2 to 4 weeks.
    One of the risks with using this product is unintentional injection into a blood vessel, and while rare,
    the complications can be serious and may be permanent. These complications, which have been
    reported for facial injections, can include vision abnormalities, blindness, stroke, temporary scabs,
    or permanent scarring.
    As with all skin injection procedures, there is a risk of infection.
    To report a side effect with JUVÉDERM VOLUMA® XC, please call Allergan Product Surveillance at
    1-800-624-4261.
    For more information, please see Juvederm.com or call Allergan Medical
    Information at 1-800-433-8871.
    Available by prescription only.

    jovuderm voluma before and after julia 2

    Actual patient. Results may vary. Unretouched photos taken before treatment and 1 month after treatment with
    JUVÉDERM VOLUMA® XC. A total of 3.0 mL of JUVÉDERM VOLUMA® XC was injected into the cheek area.

    APPROVED USE:

    JUVÉDERM VOLUMA® XC injectable gel is for deep injection in the cheek area to correct age-related
    volume loss in adults over the age of 21.
    IMPORTANT SAFETY INFORMATION
    Are there any reasons why I should not receive JUVÉDERM VOLUMA® XC?
    Do not use if you have a history of multiple severe allergies or severe allergic reactions (anaphylaxis), or
    if you are allergic to the proteins (gram-positive bacterial proteins) used to make hyaluronic acid (HA) or
    to the lidocaine in this product.
    What precautions should my doctor advise me about?
    • Tell your doctor if you are pregnant or breastfeeding. The safety of these products for use during
    pregnancy or while breastfeeding has not been studied
    • The safety of JUVÉDERM VOLUMA® XC in patients under 35 years or over 65 years has not
    been studied
    • The safety and effectiveness of JUVÉDERM VOLUMA® XC in areas other than the cheek area have
    not been established in clinical studies
    • Tell your doctor if you have a history of excessive scarring (eg, hypertrophic scarring and keloid
    formations) or pigmentation disorders, as use of these products may result in additional scars or
    changes in pigmentation
    • Tell your doctor if you are planning other laser treatments or a chemical peel, as there is a possible
    risk of inflammation at the treatment site if these procedures are performed after treatment
    • Patients who experience skin injury near the site of injection with these products may be at higher
    risk for side effects

    • Tell your doctor if you are on immunosuppressive therapy used to decrease the body’s immune
    response, as use of these products may result in an increased risk of infection
    • Tell your doctor if you are using medications that can prolong bleeding, such as aspirin, ibuprofen,
    or other blood thinners, as this may result in increased bruising or bleeding at the injection site
    • Minimize strenuous exercise, exposure to extensive sun or heat, and alcoholic beverages within
    the first 24 hours following treatment
    What are possible side effects?
    The most common side effects include temporary reactions at the treatment site such as tenderness,
    swelling, firmness, lumps/bumps, bruising, pain, redness, discoloration, and itching. Side effects are
    moderate (uncomfortable) and generally last 2 to 4 weeks.
    One of the risks with using this product is unintentional injection into a blood vessel, and while rare,
    the complications can be serious and may be permanent. These complications, which have been
    reported for facial injections, can include vision abnormalities, blindness, stroke, temporary scabs,
    or permanent scarring.
    As with all skin injection procedures, there is a risk of infection.
    To report a side effect with JUVÉDERM VOLUMA® XC, please call Allergan Product Surveillance at
    1-800-624-4261.
    For more information, please see Juvederm.com or call Allergan Medical
    Information at 1-800-433-8871.
    Available by prescription only.

    jovuderm voluma before and after julia 3

    Actual patient. Results may vary. Unretouched photos taken before treatment and 1 month after treatment with
    JUVÉDERM VOLUMA® XC. A total of 3.0 mL of JUVÉDERM VOLUMA® XC was injected into the cheek area.

    APPROVED USE:

    JUVÉDERM VOLUMA® XC injectable gel is for deep injection in the cheek area to correct age-related
    volume loss in adults over the age of 21.
    IMPORTANT SAFETY INFORMATION
    Are there any reasons why I should not receive JUVÉDERM VOLUMA® XC?
    Do not use if you have a history of multiple severe allergies or severe allergic reactions (anaphylaxis), or
    if you are allergic to the proteins (gram-positive bacterial proteins) used to make hyaluronic acid (HA) or
    to the lidocaine in this product.
    What precautions should my doctor advise me about?
    • Tell your doctor if you are pregnant or breastfeeding. The safety of these products for use during
    pregnancy or while breastfeeding has not been studied
    • The safety of JUVÉDERM VOLUMA® XC in patients under 35 years or over 65 years has not
    been studied
    • The safety and effectiveness of JUVÉDERM VOLUMA® XC in areas other than the cheek area have
    not been established in clinical studies
    • Tell your doctor if you have a history of excessive scarring (eg, hypertrophic scarring and keloid
    formations) or pigmentation disorders, as use of these products may result in additional scars or
    changes in pigmentation
    • Tell your doctor if you are planning other laser treatments or a chemical peel, as there is a possible
    risk of inflammation at the treatment site if these procedures are performed after treatment
    • Patients who experience skin injury near the site of injection with these products may be at higher
    risk for side effects

    • Tell your doctor if you are on immunosuppressive therapy used to decrease the body’s immune
    response, as use of these products may result in an increased risk of infection
    • Tell your doctor if you are using medications that can prolong bleeding, such as aspirin, ibuprofen,
    or other blood thinners, as this may result in increased bruising or bleeding at the injection site
    • Minimize strenuous exercise, exposure to extensive sun or heat, and alcoholic beverages within
    the first 24 hours following treatment
    What are possible side effects?
    The most common side effects include temporary reactions at the treatment site such as tenderness,
    swelling, firmness, lumps/bumps, bruising, pain, redness, discoloration, and itching. Side effects are
    moderate (uncomfortable) and generally last 2 to 4 weeks.
    One of the risks with using this product is unintentional injection into a blood vessel, and while rare,
    the complications can be serious and may be permanent. These complications, which have been
    reported for facial injections, can include vision abnormalities, blindness, stroke, temporary scabs,
    or permanent scarring.
    As with all skin injection procedures, there is a risk of infection.
    To report a side effect with JUVÉDERM VOLUMA® XC, please call Allergan Product Surveillance at
    1-800-624-4261.
    For more information, please see Juvederm.com or call Allergan Medical
    Information at 1-800-433-8871.
    Available by prescription only.

    jovuderm voluma before and after julia

    Actual patient. Results may vary. Unretouched photos taken before treatment and 1 month after treatment with
    JUVÉDERM VOLUMA® XC. A total of 3.0 mL of JUVÉDERM VOLUMA® XC was injected into the cheek area.

    APPROVED USE:

    JUVÉDERM VOLUMA® XC injectable gel is for deep injection in the cheek area to correct age-related
    volume loss in adults over the age of 21.
    IMPORTANT SAFETY INFORMATION
    Are there any reasons why I should not receive JUVÉDERM VOLUMA® XC?
    Do not use if you have a history of multiple severe allergies or severe allergic reactions (anaphylaxis), or
    if you are allergic to the proteins (gram-positive bacterial proteins) used to make hyaluronic acid (HA) or
    to the lidocaine in this product.
    What precautions should my doctor advise me about?
    • Tell your doctor if you are pregnant or breastfeeding. The safety of these products for use during
    pregnancy or while breastfeeding has not been studied
    • The safety of JUVÉDERM VOLUMA® XC in patients under 35 years or over 65 years has not
    been studied
    • The safety and effectiveness of JUVÉDERM VOLUMA® XC in areas other than the cheek area have
    not been established in clinical studies
    • Tell your doctor if you have a history of excessive scarring (eg, hypertrophic scarring and keloid
    formations) or pigmentation disorders, as use of these products may result in additional scars or
    changes in pigmentation
    • Tell your doctor if you are planning other laser treatments or a chemical peel, as there is a possible
    risk of inflammation at the treatment site if these procedures are performed after treatment
    • Patients who experience skin injury near the site of injection with these products may be at higher
    risk for side effects

    • Tell your doctor if you are on immunosuppressive therapy used to decrease the body’s immune
    response, as use of these products may result in an increased risk of infection
    • Tell your doctor if you are using medications that can prolong bleeding, such as aspirin, ibuprofen,
    or other blood thinners, as this may result in increased bruising or bleeding at the injection site
    • Minimize strenuous exercise, exposure to extensive sun or heat, and alcoholic beverages within
    the first 24 hours following treatment
    What are possible side effects?
    The most common side effects include temporary reactions at the treatment site such as tenderness,
    swelling, firmness, lumps/bumps, bruising, pain, redness, discoloration, and itching. Side effects are
    moderate (uncomfortable) and generally last 2 to 4 weeks.
    One of the risks with using this product is unintentional injection into a blood vessel, and while rare,
    the complications can be serious and may be permanent. These complications, which have been
    reported for facial injections, can include vision abnormalities, blindness, stroke, temporary scabs,
    or permanent scarring.
    As with all skin injection procedures, there is a risk of infection.
    To report a side effect with JUVÉDERM VOLUMA® XC, please call Allergan Product Surveillance at
    1-800-624-4261.
    For more information, please see Juvederm.com or call Allergan Medical
    Information at 1-800-433-8871.
    Available by prescription only.

    Book Your Appointment Today

    Location

    241 Golf Mill Center #405,
    Niles, Illinois 60714

    Our hours

    Thursday 3:00 PM – 7:00 PM
    Friday 2:00PM – 7:00 PM
    Saturday 9:00 AM – 4:00 PM

    Contact us

    Phone: (312) 972-6236

    0/5 (0 Reviews)
    Close Menu
    Click to Call